06622 兆科眼科－Ｂ
按盘价 
1.340 0.000 (0.000%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -15.429% | -15.739% | -111.158% | -81.647% | -22.027% |
| 股东资金回报率 (%) | -17.515% | -16.818% | -243.470% | N/A | 478.133% |
| 资本运用回报率 (%) | -18.477% | -17.142% | -84.636% | -61.980% | -32.960% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 75.984% | N/A | N/A | N/A | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | -2161.397% | N/A | N/A | N/A | N/A |
| 税前边际利润率 (%) | -2050.603% | N/A | N/A | N/A | N/A |
| 纯利率 (%) | -2053.536% | N/A | N/A | N/A | N/A |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 5.334 X | 10.141 X | 24.817 X | 17.024 X | 2.065 X |
| 速动比率 (X) | 5.316 X | 10.141 X | 24.817 X | 17.024 X | 2.065 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 15.371% | 8.646% | 4.219% | 160.817% | 104.607% |
| 总债项 / 总资产比率 (%) | 9.834% | 5.132% | 1.421% | 3.059% | 5.556% |
| 净债项 / 总资产比率 (%) | -50.555% | -61.636% | -80.271% | -2.248% | -22.370% |
| 总债项 / 股东资金比率 (%) | 11.621% | 5.618% | 1.484% | N/A | N/A |
| 长期债项 / 股东资金比率 (%) | 1.067% | 1.180% | 0.836% | N/A | N/A |
| 净债项 / 股东资金比率 (%) | -59.737% | -67.469% | -83.807% | N/A | N/A |
| 净现金 / (债项) ($) | 12.24亿 | 15.84亿 | 20.91亿 | 2.76千万 | 1.24亿 |
| 每股净现金 / (债项) ($) | 2.240 | 2.913 | 3.859 | -- | -- |
| 总债项 / 资本运用比率 (%) | 11.422% | 5.552% | 1.472% | 3.199% | 8.313% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 497.771日 | N/A | N/A | N/A | -- |
| 应收贸易帐周转率日数 (日) | 72.221日 | N/A | N/A | N/A | N/A |
| 应付贸易帐周转率日数 (日) | 22.698日 | N/A | N/A | N/A | N/A |
| 备注： | 实时报价更新时间为29/11/2024 12:44 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -75,802,000 |
| 增长率 | -67.575% |
| 每股盈利/(亏损) | RMB -0.140 |
| 每股账面资产净值 (¥) | RMB 3.723 |